Free Trial

Ocugen (OCGN) Insider Trading & Ownership

Ocugen logo
$0.77 +0.00 (+0.27%)
(As of 12/20/2024 05:45 PM ET)

Ocugen (NASDAQ:OCGN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.29%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$9,100.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get OCGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ocugen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OCGN Insider Buying and Selling by Quarter

Ocugen Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/26/2024Prabhavathi FernandesDirectorBuy10,000$0.91$9,100.00  
(Data available from 1/1/2013 forward)

OCGN Insider Trading Activity - Frequently Asked Questions

4.29% of Ocugen stock is owned by insiders. Learn more on OCGN's insider holdings.

The following insiders have purchased OCGN shares in the last 24 months: Junge Zhang ($100,139.00), and Prabhavathi Fernandes ($9,100.00).

Insiders have purchased a total of 210,278 OCGN shares in the last 24 months for a total of $109,239.00 bought.

The following insider sold OCGN shares in the last 24 months: Shankar Musunuri ($128,000.00).

Insiders have sold a total of 100,000 Ocugen shares in the last 24 months for a total of $128,000.00 sold.

Ocugen Key Executives

  • Dr. Shankar Musunuri M.B.A. (Age 60)
    Ph.D., Co-Founder, CEO & Chairman
    Compensation: $864.25k
  • Dr. Uday B. Kompella Ph.D. (Age 57)
    Co-founder & Independent Director
    Compensation: $60k
  • Mr. Michael Breininger CPA (Age 41)
    M.B.A., Chief Accounting Officer & Corporate Controller
    Compensation: $226.94k
  • Dr. Arun Upadhyay Ph.D. (Age 41)
    Chief Scientific Officer and Head of Research & Development
    Compensation: $598.06k
  • John Kouch J.D.
    General Counsel
  • Ms. Tiffany J. Hamilton M.B.A.
    AVP & Head of Corporate Communications
  • Ms. Kristen Craft
    Head of People & Culture
  • Mr. Michael Shine M.B.A.
    Senior Vice President of Commercial
  • Ms. Jyothy Pillai M.S.
    VP & Head of Regulatory & Quality
  • Dr. Huma Qamar CMI (Age 40)
    M.D., M.P.H., Chief Medical Officer


This page (NASDAQ:OCGN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners